WallStSmart

Hitek Global Inc. Ordinary Share (HKIT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 14181% more annual revenue ($258.90M vs $1.81M). ZEPP leads profitability with a -15.5% profit margin vs -106.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

HKIT

Avoid

21

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 8.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HKITUndervalued (+65.3%)

Margin of Safety

+65.3%

Fair Value

$5.71

Current Price

$0.82

$4.89 discount

UndervaluedFair: $5.71Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HKIT2 strengths · Avg: 10.0/10
P/E RatioValuation
0.8x10/10

Attractively priced relative to earnings

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

HKIT4 concerns · Avg: 2.3/10
Market CapQuality
$7.74M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-6.2%2/10

ROE of -6.2% — below average capital efficiency

Revenue GrowthGrowth
-59.6%2/10

Revenue declined 59.6%

EPS GrowthGrowth
-83.5%2/10

Earnings declined 83.5%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HKIT

The strongest argument for HKIT centers on P/E Ratio, Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : HKIT

The primary concerns for HKIT are Market Cap, Return on Equity, Revenue Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

HKIT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

HKIT carries more volatility with a beta of 2.86 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 21/100) and 43.0% revenue growth. HKIT offers better value entry with a 65.3% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hitek Global Inc. Ordinary Share

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Hitek Global Inc. (HKIT) is a forward-looking technology firm that specializes in blockchain and digital asset solutions, providing enhanced security and scalability for enterprises navigating the evolving digital landscape. As demand for blockchain technology grows across diverse industries, Hitek aims to leverage these trends to generate sustainable shareholder value. With a strong emphasis on strategic partnerships and continuous innovation, the company is poised to play a significant role in digital transformation, enabling businesses to excel in the competitive digital economy.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?